Home Compare BMY vs MO
Stock Comparison · Structural lead, mixed market

Bristol-Myers Squibb Company vs Altria Group: Which Stock Looks Stronger in 2026?

Altria holds the cleaner structural position, with the lead spread across profitability and growth. Bristol-Myers Squibb Company does not offset that deficit through any equally strong structural edge elsewhere. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.

Updated 2026-05-17

The lead is spread across profitability and growth, rather than sitting in one isolated gap. The overall score gap is 23 points in favour of Altria Group, Inc..

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #12
within Bristol-Myers Squibb Company's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

Most of the shared profile comes through recent revenue growth and capital structure.

Similarity drivers
recent revenue growthcapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BMY
Bristol-Myers Squibb Company
56
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
MO
Altria Group, Inc.
79
Peer-Score
Signal qualitylow
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BMY vs MO Profitability 40 90 Stability 59 72 Valuation 86 86 Growth 30 60 BMY MO
Gap Ranking
#1 Profitability +50
#2 Growth +30
#3 Stability +13
#4 Valuation
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BMY and MO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BMYMO Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where BMY and MO each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY BMY Neutral · near norm 0th 50th 100th 30 pct gap MO Elevated · above norm 0th 50th 100th 69th 99th
Today BMY sits in the upper-middle of its own 5-year history (69th percentile), while MO sits higher in its own history (99th). Within each stock's own 5-year context, BMY is at a historically more favourable entry position than MO. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Profitability
Both rank well on profitability, but Altria Group, Inc. still holds a clear edge.
Growth
On growth, Altria Group, Inc. is positioned higher in the group, while Bristol-Myers Squibb Company is closer to the middle.
Profitability — Dominant Gap
BMY
40
MO
90
Gap+50in favour of MO

The profitability lead is mainly driven by a 29-point operating margin advantage.

What keeps the gap from being one-sided

Bristol-Myers Squibb Company still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both profitability and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the BMY vs MO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-growth comparisons

Explore how BMY and MO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.